arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Relay Therapeutics, Inc.

RLAY Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$13.52
▼ -7.0% Today
as of Jun 7, 07:26 ET
Last 30 days +3.76% Apr 28 → Jun 05
$11.78 $12.83 $13.88 $14.94 $15.99 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$14.54
High
$14.54
Low
$12.93
Volume
$6M
Avg Vol
$3M
Mkt Cap
$2.7B
P/E (TTM)
Beta
52w High
$17.47
52w Low
$2.98
Div Yield
Shares Out
$189M

Overview

52-week range
$2.98
$17
73% of range
Avg surprise (last 2)
-4.6%
Avg reaction (last 2)
+0.7%
50% positive
Latest IV / EM
208%
EM ±28.8% · $14 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.81$-0.70$-0.58$-0.46$-0.35 Actual $-0.81Actual $-0.54Actual $-0.62Actual $-0.69Actual $-0.63Actual $-0.46Est $-0.50Actual $-0.41Actual $-0.43Actual $-0.41Est $-0.35 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-92M$-67M$-42M$-17M$8M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-0.41 $-0.35 -17.1% +10.9% -0.7% earnings
Tue Sep 30, 2025Sep 2025 $-0.43 financials
Mon Jun 30, 2025Jun 2025 $-0.41 financials
Mon May 5, 2025Mar/2025 $-0.46 $-0.50 +8.0% +2.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.63 financials
Sun Jun 30, 2024Jun 2024 $-0.69 financials
Sun Mar 31, 2024Mar 2024 $-0.62 financials
Sat Sep 30, 2023Sep 2023 $-0.54 financials
Fri Jun 30, 2023Jun 2023 $-0.81 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$3M$0$677,000$8M$0$0
Cost of revenue
Gross profit
Operating income$-79M$-80M$-77M$-85M$-96M$-101M
Net income$-73M$-74M$-70M$-77M$-88M$-92M
EPS (diluted)$-0.41$-0.43$-0.41$-0.46$-0.63$-0.69

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$205M$84M$92M$114M$94M$124M$152M$134M
Inventory
Total current assets$658M$578M$624M$680M$740M$809M$865M$704M
Total assets$700M$621M$670M$729M$799M$871M$930M$773M
Long-term debt
Total liabilities$57M$54M$62M$63M$78M$94M$91M$91M
Total equity$642M$567M$608M$666M$721M$778M$839M$682M

Implied volatility — last 90 days

203%205%208%210%213% Jun 07 — IV 208% · EM ±28.8%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.